Stock Market News2 months Nektar Q3 Loss Narrower Than Expected, Pipeline Development in Focus Zacks
NKTR reports encouraging third-quarter results as both earnings and revenues beat estimates. Product sales increase year over year.
X1 month Multiple Catalysts Ahead For Nektar Therapeutics Seeking Alpha
X2 months Nektar Therapeutics (NKTR) Q3 2024 Earnings Call Transcript Seeking Alpha
X2 months Nektar Therapeutics (NKTR) Reports Q3 Loss, Tops Revenue Estimates Zacks
X2 months Nektar Therapeutics (NASDAQ:NKTR) Short Interest Update MarketBeat
XThe Stock Market News
TheStockMarketNews.com is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds, rates and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.